--- title: "Iqvia Holdings Officer Sold Shares Worth Over $1.2M" type: "News" locale: "en" url: "https://longbridge.com/en/news/294556963.md" description: "Sherbet Eric, an Officer serving as Executive Vice President, General Counsel, reported a direct sale of common stock on 2026-07-29. The shares were sold at $249.16 per share. The total sale amount reported was $1,245,800. Following the transaction, Sherbet Eric directly owns 20,999 common shares. The filing notes a power of attorney.Reporter NameSherbet EricRelationshipOfficerTypeSellAmount$1,245,800SEC FilingForm 4DisclaimerThis is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC." datetime: "2026-07-31T21:10:01.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294556963.md) - [en](https://longbridge.com/en/news/294556963.md) - [zh-HK](https://longbridge.com/zh-HK/news/294556963.md) generator: "portal-rs" --- # Iqvia Holdings Officer Sold Shares Worth Over $1.2M Sherbet Eric, an Officer serving as Executive Vice President, General Counsel, reported a direct sale of common stock on 2026-07-29. The shares were sold at $249.16 per share. The total sale amount reported was $1,245,800. Following the transaction, Sherbet Eric directly owns 20,999 common shares. The filing notes a power of attorney. Reporter Name Sherbet Eric Relationship Officer Type Sell Amount $1,245,800 SEC Filing Form 4 **Disclaimer** This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC. ### Related Stocks - [IQV.US](https://longbridge.com/en/quote/IQV.US.md) ## Related News & Research - [Nichols & Pratt Advisers LLP MA Grows Stake in IQVIA Holdings Inc. $IQV](https://longbridge.com/en/news/297423755.md) - [10:30 ETClinical Trials Services Market worth $97.41 billion by 2031 - Exclusive Report by MarketsandMarkets™](https://longbridge.com/en/news/298051641.md) - [CRET: Q2 2026 saw higher sales and improved margins, but growth is limited by financing constraints](https://longbridge.com/en/news/297468890.md) - [IZAFE_B: Sales surged but losses deepened; focus shifts to recurring revenue and faster installations](https://longbridge.com/en/news/297468868.md) - [SOTL: Record revenue, margin expansion, and innovation drive robust growth and future optimism](https://longbridge.com/en/news/297615048.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**